[Edaily Starin JOO MEE_HEE Reporter] NCT members Runjun and Chen Le are kicking off their fan meeting tour in China, marking the start of their full-scale activities there. As the two members have solidified their standing in China through individual music projects and variety shows, local fans are showing high interest in this tour. (Photo courtesy of SM Entertainment) According to their agency, SM Entertainment, on the 5th, the “2026 Runjun & Chen Le Fan Meeting [Roommate]” will be held sequentially in five Chinese cities, starting in Hangzhou on this day, followed by Beijing on the 11th, Chengdu on the 17th, Guangzhou on the 19th, and Shanghai on the 25th. This fan meeting was planned around the concept of Renjun and Chen Lu becoming “roommates” with their fans. In addition to heartfelt interactions in a relaxed atmosphere, the event will feature special performances and segments exclusive to this tour. Previously, Renjun dominated major local music charts with his Chinese special EP *Echoes Between Us*, released last month. The album earned a “Triple Gold Album” certification from China’s QQ Music and topped major charts, including New Songs, Trend Peak, Rising, Popular Songs, Trend Index, and Digital Album Sales. He also achieved success on international charts, including reaching No. 1 on the JOOX Top Music Chart in Indonesia. Chen Le also had her solo talents recognized when she won the “Breakthrough Trending Artist of the Year” award at the “TMEA 2025” for her Chinese special EP “Lucid,” released last May. Furthermore, she appeared on the Chinese variety show “The Chorus of First Youth,” which aired from April to June of this year, where she showcased her vocal skills and variety show charisma, capturing the attention of local viewers.
Lotte Construction has completely cleared its “long-standing debt” by receiving full payment for construction work on the 5 trillion won “ LOTTE CHEMICAL CORPORATION(011170) ” “LINE” project in Indone…
On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
AprilBio Co.,Ltd.(397030)has decided to explore other indications for “APB-A1” (Lu AG22515), a technology it licensed to Lundbeck, after the compound failed to demonstrate the expected clinical effica…